MarketCapTrends
VYNE

Vyne Therapeutics Inc. (VYNE)

NASDAQ · Healthcare

Vyne Therapeutics Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Vyne Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 2.4M, a 83.84% decrease year-over-year.
  • Vyne Therapeutics Inc. total liabilities for 2025 were 2.4M, a 83.84% decrease from 2024.
  • Vyne Therapeutics Inc. total liabilities for 2024 were 14.8M, a 65.58% increase from 2023.
  • Vyne Therapeutics Inc. total liabilities for 2023 were 8.9M, a 4.23% decrease from 2022.
  • Vyne Therapeutics Inc. total liabilities for 2022 were 9.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Vyne Therapeutics Inc. Annual Total Liabilities (Millions of US $)
2025$2
2024$15
2023$9
2022$9
2021$18
2020$56
2019$64
2018$10
2017$15
2016$12
Vyne Therapeutics Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$2
2024-12-31$15
2023-12-31$9
2022-12-31$9
2021-12-31$18
2020-12-31$56
2019-12-31$64
2018-12-31$10
2017-12-31$15
2016-12-31$12

Vyne Therapeutics Inc. Total Liabilities — FAQ

Vyne Therapeutics Inc. (VYNE) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VYNE's total liabilities history?

The chart and table above show Vyne Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.